1. Home
  2. TKC vs GKOS Comparison

TKC vs GKOS Comparison

Compare TKC & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Turkcell Iletisim Hizmetleri AS

TKC

Turkcell Iletisim Hizmetleri AS

HOLD

Current Price

$5.91

Market Cap

5.2B

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$113.41

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TKC
GKOS
Founded
1993
1998
Country
Turkey
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
5.4B
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
TKC
GKOS
Price
$5.91
$113.41
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
$123.62
AVG Volume (30 Days)
903.5K
877.3K
Earning Date
11-06-2025
10-29-2025
Dividend Yield
3.96%
N/A
EPS Growth
N/A
N/A
EPS
0.11
N/A
Revenue
$4,451,876,110.00
$469,820,000.00
Revenue This Year
$42.76
$31.15
Revenue Next Year
$29.15
$24.15
P/E Ratio
$22.64
N/A
Revenue Growth
N/A
30.38
52 Week Low
$5.35
$73.16
52 Week High
$7.63
$163.71

Technical Indicators

Market Signals
Indicator
TKC
GKOS
Relative Strength Index (RSI) 53.05 73.39
Support Level $5.86 $105.88
Resistance Level $6.15 $110.87
Average True Range (ATR) 0.07 3.17
MACD 0.02 -0.02
Stochastic Oscillator 52.53 73.91

Price Performance

Historical Comparison
TKC
GKOS

About TKC Turkcell Iletisim Hizmetleri AS

Turkcell Iletisim Hizmetleri AS provides mobile telephone services in Turkey. The firm's services portfolio includes high-quality mobile and fixed voice, data, TV, and digital services over its network. The firm also operates in the Turkish Republic of Northern Cyprus, Belarus, the Netherlands, and Ukraine. It has three main reportable segments: Turkcell Turkiye, Turkcell International, and Techfin. The Turkcell Turkiye segment, which derives the majority of revenue, comprises mainly telecommunication and technology services activities.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: